GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Mar 31, 2017 · 10-K · 90 days after period end · 0001654954-17-002919
derived · Computed from the longer spans the company filed.
| Metric | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $33.00K | — |
| Net Income | -$2.83M | -$26.11M | -$18.64M | -$331.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end
